BRIEF-Resverlogix announces fifth positive recommendation from Data Safety Monitoring Board for Apabetalone
November 01, 2017 at 08:41 AM EDT
* Resverlogix announces fifth positive recommendation from Data Safety Monitoring Board for phase 3 study of Apabetalone